单剂百白破和脊灰疫苗足以让多数移民儿童产生破伤风加强应答
仅1.4%的儿童需要额外剂次,提示在高基础免疫覆盖率背景下,单剂策略结合血清学检测可避免完整再接种。
要点
- 无接种证明的移民儿童中,仅1.4%在单剂含破伤风类毒素疫苗后需额外剂次。
- 抗破伤风抗体≥1 IU/mL视为加强型应答,无需追加剂次。
- 叙利亚来源和直接乘飞机抵达瑞士与更高抗体水平相关。
核心结论
- 单剂含破伤风类毒素疫苗足以让多数移民儿童产生长期保护。
主要发现
- 仅3名(1.4%)儿童需要额外疫苗剂次。
- 叙利亚来源(p < 0.001)和直接乘飞机抵达瑞士而未过境其他欧洲国家(p = 0.029)与更高抗破伤风抗体水平相关(multiple r2 = 0.210,p < 0.001)。
关键数值与推荐
- 接种单剂含破伤风类毒素疫苗后4-6周检测抗破伤风抗体,≥1 IU/mL视为加强型应答且无需额外剂次。
- 在可进行血清学检测且经济可行的条件下,可考虑单剂疫苗后血清学检测策略。
临床怎么用
- 对无接种证明的移民儿童,可先给予单剂含破伤风类毒素疫苗,再通过血清学检测判断是否需要追加剂次。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immunization coverage for three doses of the diphtheria-tetanus-pertussis and poliomyelitis vaccines in infants is high worldwide, therefore despite the lack of documentation of past vaccinations, most migrant children do not require complete revaccination. Our strategy was to administer a single dose of a tetanus toxoid containing vaccine (TTCV) to migrant children followed by anti-tetanus toxoid (TT) serology to determine whether additional vaccine doses were required. Our goal was to estimate the basic TTCV coverage and to identify potential determinants of the vaccination response. METHODS: Newly arrived migrant children were prospectively enrolled between October 2014 and August 2017. We included patients aged 1-18 years with no proof of past vaccinations who accepted a single dose of TTCV. Anti-TT serology was performed after 4-6 weeks, and an anti-TT level ≥ 1 IU/mL was considered a booster-type antibody response with no need for additional doses of TTCV. Potential determinants of the vaccination response were identified using univariate and multivariate linear regression analyses. RESULTS: Two hundred and eight children were eligible for analysis. The mean age of the children was 9 (±4.5) years and 100 (48%) were female. The majority (n = 129, 62%) of the children came from the WHO Eastern Mediterranean region. Only three patients (1.4%) required additional vaccine doses. A Syrian origin (p < 0.001) and direct arrival primarily by airplane into Switzerland without transiting through other European countries (p = 0.029) associated with higher anti-TT levels in a multivariate regression model (multiple r2 = 0.210, p < 0.001). CONCLUSION: A single dose of TTCV is enough to generate long-term protection in most migrant children. In the context of high basic vaccination coverage, the strategy, which consists of administration of a single dose of TTCV followed by anti-TT serology, can be considered where serotesting is available and economical.
引用
- Fougère Y, El Houss S, Suris JC, et al. Single doses of diphtheria-tetanus-pertussis and poliomyelitis vaccines are sufficient to generate a booster-type response to tetanus in most migrant children. Vaccine. 2019. PMID: 31522805. doi:10.1016/j.vaccine.2019.08.089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。